title: Viral respiratory infection and the link to asthma.
abstract: Viral respiratory infections are closely associated with wheezing illnesses and exacerbations of asthma throughout childhood, and yet there are a number of remaining questions pertaining to the specific nature of this relationship. Infection with an expanding list of respiratory viruses is an important cause of acute wheezing in infancy, and viruses are detected in most exacerbations of asthma throughout childhood. Furthermore, infants who develop severe viral respiratory infections are more likely to have asthma later in childhood. There has been progress in understanding the pathogenesis of viral respiratory illnesses, and this has led to new insights into how these processes might differ in asthma. Several host factors, including respiratory allergy and virus-induced interferon responses, modify the risk of virus-induced wheezing. In the absence of effective antiviral therapies, treatment of virus-induced wheezing and exacerbations of asthma can be challenging, and studies evaluating current treatment strategies are reviewed. Understanding the host-pathogen interactions that determine the severity of respiratory illnesses and long-term sequelae is likely to be of great help in identifying at-risk individuals, and in designing new and more effective treatments.
authors.affiliation: Division of Pediatric Allergy, Immunology, and Rheumatology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA. gern@medicine.wisc.edu
authors.forename: James E
authors.initials: JE
authors.lastname: Gern
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy / Q000209:etiology / Q000276:immunology; D016535:Bronchial Hyperreactivity / Q000150:complications / Q000276:immunology; D001990:Bronchiolitis, Viral / Q000150:complications / Q000188:drug therapy / Q000276:immunology; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D006801:Humans; D006920:Hygiene; D006967:Hypersensitivity / Q000276:immunology; D007223:Infant; D007231:Infant, Newborn; D007249:Inflammation; D020024:Leukotriene Antagonists / Q000627:therapeutic use; D008168:Lung / Q000276:immunology / Q000821:virology; D012135:Respiratory Sounds / Q000209:etiology / Q000276:immunology; D018357:Respiratory Syncytial Virus Infections / Q000150:complications / Q000188:drug therapy / Q000276:immunology; D012136:Respiratory Syncytial Viruses / Q000276:immunology*; D012141:Respiratory Tract Infections / Q000150:complications / Q000188:drug therapy / Q000276:immunology; D014777:Virus Diseases / Q000150:complications / Q000188:drug therapy / Q000276:immunology
chemical_list: D000893:Anti-Inflammatory Agents; D000998:Antiviral Agents; D001993:Bronchodilator Agents; D020024:Leukotriene Antagonists